 Ozempic and drugs like them may lower diabetes patients' risk of developing some types of cancer, but the study in the Journal of the American Medical Association also finds the drugs didn't perform better than metformin, which does the same thing. On Wall Street, records for the NASDAQ and S&P in gains of two-tenths to almost one percent. The Dow up 68, the NASDAQ 164, the S&P 30. Joan Doniger, Bloomberg Radio.